Glutathione Protocol

Evidence Level: Emerging Evidence

Human and/or animal research exists and is accumulating, but the evidence base is not yet as extensive as an approved medicine.

Human evidence: Extensive biochemical and some clinical-outcome literature for antioxidant/detoxification research; skin-brightening claims have comparatively weaker controlled-trial support.

Animal evidence: Foundational redox-biology literature.

Introduction & Mechanism of Action

Master antioxidant tripeptide studied for oxidative-stress, detoxification and skin-brightening research.

Endogenous tripeptide (glutamate-cysteine-glycine) central to cellular redox balance and phase-II liver detoxification; exogenous supplementation is studied for boosting systemic antioxidant capacity.

Receptors/targets: Not receptor-mediated — acts as a direct antioxidant and enzyme cofactor

Areas of Research Interest

• Antioxidant research
• Detoxification-pathway studies
• Skin-brightening research

Benefits Reported in Research

• Antioxidant research
• Detoxification-pathway studies
• Skin-brightening research

Reported Research Dosing Range

The figures below are cited from published research literature and protocol references — they describe what has been studied, not a personal prescription or instruction.

Reported range: 200–600 mg

Reported frequency: 1–3× weekly, subcutaneous or IV research use

Reported cycle duration: 4–8 weeks

Escalation & maintenance: A dedicated weekly escalation and maintenance schedule specific to this peptide has not yet been published here — follow the dose range and frequency above, titrating conservatively from the low end, and consult a physician before adjusting.

Research Reference Data

Published research on Glutathione reports administration at 200–600 mg via subcutaneous or iv research use route. The table below cites that published research — it is not an individualized instruction.

Reconstitution Reference

Published research protocols reconstitute a 500 mg vial with 2 mL bacteriostatic water, yielding a concentration of 250.00 mg/mL. This is cited reference information, not a personalized preparation instruction — use the general research calculator below for your own reference computation.

Research Protocol Timeline

A reference summary of how this compound is described across published research — formulation, reported administration, and reported cycle length.

Dilution Guide

Reconstitute with 2 mL bacteriostatic water

Bacteriostatic Water (BAC Water) is the only recommended diluent. Do not dilute with sterile water, normal saline, lidocaine, or any other solution unless explicitly specified by the manufacturer.

Handling Guide

General laboratory handling practice cited for reference — not a personalized instruction. Any human use should follow the guidance of a licensed physician.

Wash hands and clean the injection site with an alcohol swab. Pinch a fold of skin and insert the needle at a 45–90° angle for standard subcutaneous injection (abdomen, thigh, or upper arm). Inject slowly, withdraw, and apply gentle pressure. Rotate injection sites to reduce irritation, and dispose of needles in an approved sharps container.

Storage

Store lyophilized (powder) vials in a freezer at -20°C, protected from light. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within the timeframe recommended in your supplier documentation — typically 2–4 weeks.

Monitoring

Monitor for injection-site reactions and the side effects listed above. Stop use and consult a physician if severe or persistent reactions occur. This is a general monitoring guideline, not a personalized medical monitoring plan.

Side Effects

• Injection-site reaction
• Rare allergic-type reactions

Contraindications

• Known hypersensitivity
• Asthma (rare reports of bronchospasm with inhaled/nebulized forms specifically, not the injectable route)

Drug interactions

• May theoretically alter the metabolism of drugs cleared via glutathione-conjugation pathways (phase-II liver detoxification)

Safety

• Generally well-tolerated; injectable cosmetic use is less regulated than clinical antioxidant research use

Skin-lightening claims exceed robust human trial evidence; injectable cosmetic use carries its own safety-data gaps.

Expected Results & Comparison

Glutathione's antioxidant mechanism is distinct from the immune-signaling mechanisms of Thymosin Alpha-1 and KPV — it is grouped in Immune Support for its detoxification/oxidative-stress research angle, not because it directly modulates immune-cell signaling the way the other two do.

References

Continue